Results 31 to 40 of about 7,152,333 (341)

Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion

open access: yesCell Research, 2020
The recent outbreak of coronavirus disease (COVID-19) caused by SARS-CoV-2 infection in Wuhan, China has posed a serious threat to global public health.
Shuai Xia   +15 more
semanticscholar   +1 more source

In silico evaluation of the interaction between ACE2 and SARS-CoV-2 Spike protein in a hyperglycemic environment

open access: yesScientific Reports, 2021
The worse outcome of COVID-19 in people with diabetes mellitus could be related to the non-enzymatic glycation of human ACE2, leading to a more susceptible interaction with virus Spike protein.
Giovanni Sartore   +5 more
doaj   +1 more source

Production and secretion of functional SARS-CoV-2 spike protein in Chlamydomonas reinhardtii

open access: yesFrontiers in Plant Science, 2022
The spike protein is the major protein on the surface of coronaviruses. It is therefore the prominent target of neutralizing antibodies and consequently the antigen of all currently admitted vaccines against SARS-CoV-2.
Anna Maria Kiefer   +4 more
doaj   +1 more source

Targeting the Interaction Between Spike Protein and Nucleocapsid Protein for Suppression and Detection of Human Coronavirus OC43

open access: yesFrontiers in Immunology, 2022
Human coronavirus OC43 (HCoV-OC43) is the coronavirus most associated with “common colds”, infections of the upper respiratory tract. Previously, we reported that direct interactions of nucleocapsid (N) protein and C-terminal domain of Spike protein ...
Jinsoo Kim   +11 more
doaj   +1 more source

Persistent circulation of soluble and extracellular vesicle‐linked Spike protein in individuals with postacute sequelae of COVID‐19

open access: yesJournal of Medical Virology, 2023
SARS‐CoV‐2, the causative agent of COVID‐19 disease, has resulted in the death of millions worldwide since the beginning of the pandemic in December 2019.
V. Craddock   +8 more
semanticscholar   +1 more source

A saposin-lipoprotein nanoparticle system for membrane proteins. [PDF]

open access: yes, 2016
A limiting factor in membrane protein research is the ability to solubilize and stabilize such proteins. Detergents are used most often for solubilizing membrane proteins, but they are associated with protein instability and poor compatibility with ...
Armache, Jean-Paul   +13 more
core   +2 more sources

CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells

open access: yesSignal Transduction and Targeted Therapy, 2020
In face of the everlasting battle toward COVID-19 and the rapid evolution of SARS-CoV-2, no specific and effective drugs for treating this disease have been reported until today.
Ke Wang   +44 more
semanticscholar   +1 more source

The avian coronavirus spike protein

open access: yesVirus Research, 2014
Avian coronaviruses of the genus Gammacoronavirus are represented by infectious bronchitis virus (IBV), the coronavirus of chicken. IBV causes a highly contagious disease affecting the respiratory tract and, depending on the strain, other tissues including the reproductive and urogenital tract.
I.N. Ambepitiya Wickramasinghe   +3 more
openaire   +5 more sources

Human SARS CoV ‐2 spike protein mutations [PDF]

open access: yesProteins: Structure, Function, and Bioinformatics, 2020
Abstract The human spike protein sequences from Asia, Africa, Europe, North America, South America, and Oceania were analyzed by comparing with the reference severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) protein sequence from Wuhan‐Hu‐1, China.
openaire   +2 more sources

Relative Mutant N501Y SARS-CoV-2 Spike Protein RBD Inhibition of Anti-Spike Protein IgG and ACE-2 Binding to Spike Protein Species [PDF]

open access: yes, 2021
ABSTRACTIn the SARS-CoV-2 coronavirus pandemic of 2019 (COVID-19), it has become evident that the ACE-2 receptor-binding domain (RBD) of the viral spike protein (SP) is the target of neutralizing antibodies that comprise a critical element of protective immunity to the virus.
Melvin E. Klegerman   +2 more
openaire   +1 more source

Home - About - Disclaimer - Privacy